Several companies missed profit estimates today, bucking the trend. Here's what it means for the markets....» Read More
Based on a proprietary algorithm from Chartlab Pro, here are the 10 most overbought stocks in the market right now.
While the S&P 500 has climbed 11.75 percent in the past three months, the health care sector has only managed to muster a 2.3 percent climb over the same time period. But underperformance tends to be cyclical.
In a market environment littered with deals, CNBC's Jim Cramer sees a growing divergence between market pros on the bullish and bearish ends of the spectrum.
Sarepta Therapeutics has been holding its ground for months, and now the bulls are looking for the next leg higher.
Gas prices aren't likely to continue their upward trajectory, Dennis Gartman says.
Stick with what works, Oppenheimer's John Stoltzfus says.
Despite an improving housing market and firming prices, it's going to be difficult to achieve what is already priced into the stocks, which skyrocketed last year, an analyst told CNBC.
Trian Partners chief Nelson Peltz was the second billionaire on CNBC's "Squawk Box" last week to laud the prospects of Legg Mason.
CNBC's Jim Cramer sees an important divergence between high end retailers and the rest of the sector.
Symantec has been parked at long-term resistance, and now the bulls are looking for a breakout.
If we accept that the renmimbi is on its way, banks should set up an ability to trade and settle the currency itself, as well as handle bonds and equity denominated in it, writes Moorad Choudhry.
In the last month or so, in an effort to stimulate growth, central bankers have begun a new round of creative experiments. This should lead to more market volatility and unexpected investment opportunities, particularly in currencies.
Gold bounced back from a drubbing that sent the precious metal to a six-month low late last week, however, analysts say further upside is dependent on whether gold can hold on to a key support level over the next few days.
Hedge fund manager Daniel Loeb has sold part of his long position in the nutrition company Herbalife, a source told CNBC.
Cramer said practicing this simple strategy may prevent a lot of tears in days to come.
There's an investment strategy that Jim Cramer calls "one of the greatest, most reliable ways to make money out there."
What exactly does Cramer mean by a 'spec' stock?
Hedge fund manager Bill Ackman, who made a $1 billion bet against the stock, told CNBC he remains convinced "Herbalife is a pyramid scheme," despite Carl Icahn stake.
The option trading bulls are betting that Hewlett-Packard is ready to make another move.
Warren Buffett's acquisition of Heinz is a winner, Whitney Tilson of T2 Partners says.
Get the best of CNBC in your inbox